Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The role of PET/CT in multiple myeloma

Jakob Nordberg Nørgaard • 11 Jun 2022
EHA 2022
Multiple Myeloma

Jakob Nordberg Nørgaard, PhD, Oslo University Hospital, Oslo, Norway, outlines the role of PET/CT in the diagnosis and management of multiple myeloma. PET/CT is a very sensitive technique used for the diagnosis of extramedullary disease and osteolytic lesions, as well as for risk stratification and response assessment. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Jakob Nordberg Nørgaard

2:01
CONPET: KRd consolidation in patients with multiple myeloma with a positive PET/CT after autoHSCT
Jakob Nordberg Nørgaard • 11 Jun 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals